Amrutanjan Health Care P/B Ratio
Amrutanjan Health Care (AMRUTANJAN) P/B ratio is 4.36 (High), book value per share ₹363.33 vs Healthcare average P/B of -0.33 — Very High - Significant premium, high growth expectations or speculative. For live price, earnings yield and the full fundamental profile, see AMRUTANJAN stock price BSE.
Current Valuation Metrics
Book Value Breakdown (2016)
Valuation Signal
Sector Context
AMRUTANJAN P/B Ratio — Valuation Insights & Book Value Analysis
Amrutanjan Health Care price-to-book ratio interpretation, valuation status and historical context — current P/B 4.36 (High). Compare with AMRUTANJAN fair value to assess whether the stock is under or overvalued.
- Stock appears overvalued with PB of 4.36, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Current PB is 485.2% above historical average
- Trading at premium to sector average PB of -0.33
Amrutanjan Health Care P/B Ratio Historical Trend
AMRUTANJAN annual price-to-book ratio — 2 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. View Amrutanjan Health Care yearly highs lows for the annual high/low range and current price position.
AMRUTANJAN Historical P/B Ratio — Book Value Per Share & Year-End Price
Amrutanjan Health Care annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2016 | 0.73 | ₹363.33 | ₹263.90 | ₹109 | Low |
| 2015 | 0.76 | ₹316.67 | ₹240.15 | ₹95 | Low |
AMRUTANJAN vs Healthcare Peers — P/B Ratio Comparison
Amrutanjan Health Care P/B 4.36 vs Healthcare average -0.33, median 0.63 — range -17.92–1.01.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Rekvina Laboratories | VINRKLB | -17.92 | ₹22 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Parmax Pharma | PARMAX | -2.48 | ₹14 | Low |
| Bharat Immunologicals | BIBCL | -2.32 | ₹76 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.71 | ₹127 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.63 | ₹53 | Low |